In AD brains, various isoforms of NFAT demonstrate differential activation profiles with nuclear fractions of NFAT1 (also known as NFATc2) elevated in patients with mild cognitive impairment (MCI) while nuclear fractions of NFAT3 (NFATc4) are increased in AD patient brains [38]. Here, NFATC2 is linked to Cognitive impairment.